Solleiro Vidal, Á.; Yáñez Baña, R.; Labandeira Guerra, C.; Cimas Hernando, M.I.; Cabo López, I.; Paz González, J.M.; Alonso Losada, M.G.; Santos García, D.
Effect of Safinamide on Non-Motor Symptoms and Quality of Life in Parkinson’s Disease Patients According to Sex, Age, Disease Duration and Levodopa Equivalent Daily Dose. Brain Sci. 2025, 15, 666.
https://doi.org/10.3390/brainsci15070666
AMA Style
Solleiro Vidal Á, Yáñez Baña R, Labandeira Guerra C, Cimas Hernando MI, Cabo López I, Paz González JM, Alonso Losada MG, Santos García D.
Effect of Safinamide on Non-Motor Symptoms and Quality of Life in Parkinson’s Disease Patients According to Sex, Age, Disease Duration and Levodopa Equivalent Daily Dose. Brain Sciences. 2025; 15(7):666.
https://doi.org/10.3390/brainsci15070666
Chicago/Turabian Style
Solleiro Vidal, Ángela, Rosa Yáñez Baña, Carmen Labandeira Guerra, Maria Icíar Cimas Hernando, Iria Cabo López, Jose Manuel Paz González, Maria Gema Alonso Losada, and Diego Santos García.
2025. "Effect of Safinamide on Non-Motor Symptoms and Quality of Life in Parkinson’s Disease Patients According to Sex, Age, Disease Duration and Levodopa Equivalent Daily Dose" Brain Sciences 15, no. 7: 666.
https://doi.org/10.3390/brainsci15070666
APA Style
Solleiro Vidal, Á., Yáñez Baña, R., Labandeira Guerra, C., Cimas Hernando, M. I., Cabo López, I., Paz González, J. M., Alonso Losada, M. G., & Santos García, D.
(2025). Effect of Safinamide on Non-Motor Symptoms and Quality of Life in Parkinson’s Disease Patients According to Sex, Age, Disease Duration and Levodopa Equivalent Daily Dose. Brain Sciences, 15(7), 666.
https://doi.org/10.3390/brainsci15070666
